The Florey partners in multi-institute Mental Health PhD Program
Date posted 22 September 2020 The Florey Institute of Neuroscience and Mental Health will share responsibility for shaping and steering the University of Melbourne’s Mental Health PhD program with the Centre for Mental Health, the Department of Psychiatry,…
CSIRO identifies opportunities for economic recovery
Date posted 22 September 2020 Release date 16 September 2020 A new report from Australia’s national science agency, CSIRO, has revealed the opportunities for key industries to leverage science and technology and help restore economic growth and resilience.…
Bosch virtual companion increases safety for trucks on the road
Date posted 22 September 2020 Release date 18 September 2020 Research project to develop attention and activity assistant for automated driving Break up the monotony of the drive, maintain alertness, avoid accidents. Ensure perfect interaction between truck and…
Noxopharm Appoints US Corporate Advisory and Consulting Firm
Date posted 22 September 2020 Release date 18 September 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) is pleased to announce that it has appointed US corporate advisory and consulting firm, Destum Partners, to advise on…
Immutep Reports Improving Results from INSIGHT-004 Trial
Date posted 22 September 2020 Release date 18 September 2020 41.7% of patients showed a Partial Response to the combination therapy of eftilagimod alpha and avelumab (previously 33%) Encouraging early anti-tumour activity signals in a variety of cancer…
Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study
Date posted 22 September 2020 Release date 18 September 2020 Three complete responses (complete disappearance of all lesions) reported: two in 2nd line head and neck squamous cell carcinoma (HNSCC) and one in 1st line non-small cell lung…
Technovalia partners with the Vax4COVID Alliance and BioNet to evaluate COVIGEN
Date posted 22 September 2020 Release date 20 September 2020 Technovalia partners with the Vax4COVID Alliance and BioNet to start a Phase 1 Human Vaccine Trial in Australia with COVIGEN, a COVID-19 gene-based vaccine First SARS-CoV2 DNA vaccine…
MRFF backs COVID-19 vaccine candidate
Date posted 22 September 2020 Release date 17 September 2020 Read the full media release via Monash University. The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested almost $3 million into new COVID-19 vaccine candidates led out…
Further Investment In Three New Australian COVID-19 Vaccine Research Projects
Date posted 22 September 2020 Release date 20 September 2020 The Morrison Government will invest almost $6 million in additional funding from the Medical Research Future Fund’s (MRFF) Coronavirus Research Response to support research and development of three…
A new discovery in regenerative medicine
Date posted 22 September 2020 Release date 17 September 2020 An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.…
AdAlta and GE Healthcare collaboration progresses to next stage
Date posted 22 September 2020 Release date 20 September 2020 AdAlta Limited, a clinical stage biopharmaceutical discovery and development company using i-body technology to address challenging drug targets, is pleased to announce the extension of its collaboration with…
UniMelb tool uses fat in bone and muscle to diagnose disease, predict falls and fractures
Date posted 22 September 2020 Release date 17 September 2020 Doctors will soon be able to use fat to diagnose musculoskeletal disease within seconds and predict the risk of falls and fractures in older people, thanks to a…
